Advertisement
Advertisement

CTSO

CTSO logo

Cytosorbents Corp.

0.65
USD
Sponsored
-0.01
-1.55%
Jan 30, 09:30 UTC -5
Open

CTSO Earnings Reports

Positive Surprise Ratio

CTSO beat 21 of 40 last estimates.

53%

Next Report

Date of Next Report
Mar 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.78M
/
-$0.05
Implied change from Q4 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
+6.87%
/
-64.29%

Cytosorbents Corp. earnings per share and revenue

On Jan 02, 2026, CTSO reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 11.26 million, with a --% difference. The market reacted with a +2.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 9.78 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
logo
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
logo
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
logo
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
FAQ
For Q4 2026, Cytosorbents Corp. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 2.6%, changed from $0.64 before the earnings release to $0.66 the day after.
The next earning report is scheduled for Mar 11, 2026.
Based on 5 analysts, Cytosorbents Corp. is expected to report EPS of -$0.05 and revenue of $9.78M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement